Answers are grounded in this paper and cite their sources.
Approximately 25% of patients with renal cell carcinoma (RCC) present with advanced disease. RCC primarily metastasizes to lymph nodes, adrenal glands, lungs, liver, bones, and brain, while metastasis to other sites is rare. Metastatic spread can be hematogenous, lymphatic, or through direct invasion. However, metastatic (m)RCC to the paranasal sinuses is rare. Primary malignant neoplasm is more common than metastatic cancer in the paranasal sinuses, and these occur most frequently in 40 to 60 age groups.1 Mehr et al described a rare case of oligometastatic clear cell RCC and the treatment strategies involved.2 Authors described 2 potential ways that RCC could possibly metastasize to the nasal/paranasal sinus tracts. Although it is not common for RCC to metastasize to the nasal sinuses, it has been described in previous case reports and as the presenting sign in a few cases. The key point is that RCC presenting with sinonasal metastasis includes a differential diagnosis of primary tumors, such as adenocarcinomas, angiofibromas, hemangiopericytomas, melanomas, hemangiomas, metastatic tumors from breast and lungs, and even more systemic disease such as Wegener and midline granulomas.3 In this case, while the primary tumor was only 4.9 cm on imaging, it comes to show that RCC tumors do not have to be significantly large to have metastatic potential. The patient was treated with cytoreductive radical nephrectomy. However, the 5-year rates of cancer-specific mortality associated with partial vs radical cytoreductive nephrectomy do not differ significantly (50.8% vs 53.6%), but other cause mortality was significantly lower among patients with partial cytoreductive nephrectomy (2.4% and 7.5%, respectively).4 In accordance with the CARMENA and SURTIME data, patients with mRCC considered International Metastatic RCC Database Consortium intermediate-risk and poor-risk groups with their primary tumor in place should be treated with up-front immune-oncology–based combinations. Multidisciplinary cancer management, including treatment with such category 1 evidence and cytoreductive radical nephrectomy, was appropriate in this case.
No takes yet. Share an insight, caveat, or question.
Espinales et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: